Stay updated with breaking news from Redica Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lawmakers are accusing the FDA of ignoring Neuralink's animal welfare violations and 'troubling evidence' of missing documents. Neuralink started testing its brain chip implants in January.
U.S. Food and Drug Administration inspectors found problems with record keeping and quality controls for animal experiments at Elon Musk's Neuralink, less than a month after the startup said it was cleared to test its brain implants in humans, according to an agency report reviewed by Reuters. The inspectors identified quality control lapses at the company's California animal research facility. A similar inspection at Neuralink's Texas facility did not find problems, according to agency records.
Just one month after the FDA approved Elon Musk-owned startup Neuralink to start human trials of its brain implant chip, agency inspectors found serious problems with the company's animal testing.
The inspectors identified quality control lapses at the company's California animal research facility. A similar inspection at Neuralink's Texas facility did not find problems, according to agency records. Those visits took place last year from June 12-22, and represent the FDA's sole inspections of Neuralink facilities on record.
Recent FDA inspection uncovers quality control issues in Neuralink's animal experiments. Senior expert flags a 'lack of attention to detail,' emphasizing the need for vigilance as Neuralink advances to human trials for brain implants.